Berlin hosts 1st Annual Scientific Symposium on Ultrahigh Field Magnetic Resonance

Article

The organizers warmly invite you to join them for the 1st Annual Scientific Symposium on Ultrahigh Field Magnetic Resonance, which will be held in Berlin on April 16th. The organizers include Jeanette Schulz-Menger, M.D., of the Charité & Helios Klinikum, Prof. Thoralf Niendorf, of the Max Delbrück Center for Molecular Medicine & Charité, and Bernd Ittermann, M.D., of the Physikalisch-Technische Bundesanstalt.

The organizers warmly invite you to join them for the 1st Annual Scientific Symposium on Ultrahigh Field Magnetic Resonance, which will be held in Berlin on April 16th. The organizers include Jeanette Schulz-Menger, M.D., of the Charité & Helios Klinikum, Prof. Thoralf Niendorf, of the Max Delbrück Center for Molecular Medicine & Charité, and Bernd Ittermann, M.D., of the Physikalisch-Technische Bundesanstalt.

The field of magnetic resonance has evolved rapidly over the past quarter century, allowing for new applications across a broad spectrum of basic science and clinical research areas. Today, one important development looming on the clinical MR research horizon is the move towards ultrahigh field magnetic resonance (UHF MR).

Inspired by this opportunity and motivated by the 2007 meeting of the International Society of Magnetic Resonance in Medicine, the Berlin Ultrahigh Field Facility has been set up at the Max Delbrück Center for Molecular Medicine as part of the Experimental Clinical Research Center initiative. This strategic investment is devoted to fostering science. It holds a broad range of promises for basic MR research and clinical applications with the ultimate goal of advancing the capabilities of imaging in the fields of cardiology, neuroscience, molecular medicine, and oncology, as well as others.

Realizing these opportunities, the 1st Annual Scientific Symposium will focus on clinical needs, research promises, and technical solutions in ultrahigh field MR. The symposium will provide an overview of the state of the art of (pre)clinical UHF MR, discuss the clinical relevance of UHF MR, explore future directions of UHF MR, foster explorations into ultrahigh field MR, and initiate local, regional, national, and international collaborations.

The symposium is designed to attract basic scientists and clinicians with all levels of experience and expertise ranging from students interested in imaging to advanced users. The program comprises four sessions, all balancing technical developments and clinical applications. The symposium is honored to present extraordinary speakers, including MR technology leaders and distinguished clinical experts, all bridging disciplinary boundaries together with stimulating topics. The scientific program will be paralleled by a technical exhibition and supplemented by an open day of the Berlin Ultrahigh Field facility.

Interested professionals will receive a warm welcome at the 1st Annual Scientific Symposium on Ultrahigh Field MR in Berlin. It is always worth it to visit Berlin. The city conducts the Capital-of-Science campaign this year, with the motto "Berlin-the place to be for science." Alongside MR science, Berlin has numerous historic landmarks, highlights, and cultural events to offer visitors.

www: www.mdc-berlin.de/BUFF
To register, e-mail: MRsymposium@mdc-berlin.de

For further information, please contact:

Michaela Langer
Max Delbrück Center for Molecular Medicine
phone: (+49) 30 9406 3720
fax: (+49) 30 9406 2206

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.